Arai, ToruHirata, HaruhikoHoshino, ShigenoriInoue, KojiKawase, IchiroKida, HiroshiKijima, TakashiKumagai, ToruOsaki, TadashiTachibana, IsaoTakimoto, TakayukiYanagita, MasahikoYano, YukihiroYoshida, Mitsuhiro2008-06-172008-06-172005-08-111611-2156http://hdl.handle.net/2003/2565010.17877/DE290R-8281Transforming growth factor-ß (TGF-ß) is a key factor for understanding the pathogenesis of fibrotic disorders such as idiopathic pulmonary fibrosis (IPF). We have demonstrated that interleukin-10 (IL-10) suppresses TGF-ß-induced expression of type I collagen (COL1) mRNA in a human lung fibroblast cell line (WI-38). However, the inhibitory mechanism has not yet been clearly elucidated. Thus, in the current study, we investigate the effects of IL-10 blockade of TGF-ß signaling which regulates COL1 mRNA expression. In WI-38 cells, IL-10 inhibits TGF-ß-mediated phosphorylation of both, c-Jun HN2-terminal kinase (JNK) and p38, but does not suppress TGF-ß- mediated phosphorylation of Smad2 or affect TGF-ß-upregulation of Smad7 mRNA expression. In addition, SP600125 and SB203580, specific inhibitors of JNK and p38, respectively, attenuate TGF-ß-induced COL1 mRNA expression in WI-38 cells. These results suggest that IL-10 inhibits TGF-ß-induced COL1 mRNA expression via both JNK and p38 pathways but not Smad pathways in WI-38 cells. This inhibitory mechanism may provide a novel insight into therapeutic strategies for fibrotic disorders such as IPF.enEXCLI Journal ; Vol. 4, 2005collagenIL-10JNKSmadTGF-ß610article (journal)